Background: Identification of patients with nonalcoholic fatty liver disease (NAFLD) with
advanced liver fibrosis in primary care remains an unmet need. Our primary objective was to …

Objective Non-alcoholic fatty liver disease (NAFLD) affects approximately one in four adults
of the general population, with an important minority of cases at high risk of developing …

Background & Aims The development of non-invasive liver fibrosis tests may enable earlier
identification of patients with non-alcoholic fatty liver disease (NAFLD) requiring referral to …

Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent worldwide.
Identifying high-risk patients is critical to best utilize limited health care resources. We …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver
disease worldwide. It affects an estimated 20% of the general population, based on cohort …

Background & Aims There is an unmet need to validate simple and easily available methods
that can be used in routine practice to identify those at risk of adverse outcomes from …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease worldwide. However, there is no clear consensus on optimal screening …

Summary Background Primary care practitioners (PCPs) and diabetologists are at the
frontline of potentially encountering patients with NASH. Identification of those at high risk for …

Among the large population of patients with non-alcoholic fatty liver disease (NAFLD),
identifying those with advanced disease remains challenging. Many patients are diagnosed …

Background Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder worldwide.
Several noninvasive diagnostic scoring systems have been developed to determine the …